Sertraline
Product Images NDC 64205-965

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sertraline (NDC 64205-965). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Readymeds, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Photo 2 (Photo 2)

Photo 2 (Photo 2)
This is a prescription drug called Sertraline 50mg, which comes in a pack of 30 tablets. The NDC number is 84205-965-30 and the expiration date of the medication is November 2016. The lot number is G310689.*
FDA Label Image

Photo (Photo)

Photo (Photo)
This medication is Sertraline 50mg sold in a bottle of 90 tablets. The NDC number is 64205-965-90 and its expiration date is 11/2018. The lot number is G310889.*
FDA Label Image

Chemical Structure (Sertraline HCl Tablets New Ndc 1)

FDA Label Image

Table 2 Most Common Treatment-emergent Adverse Events: Incidence In Placebo-controlled Clinical Trials (Sertraline HCl Tablets New Ndc 2)

Table 2 Most Common Treatment-emergent Adverse Events: Incidence In Placebo-controlled Clinical Trials (Sertraline HCl Tablets New Ndc 2)
The text appears to be a table showing the most common treatment-emergent adverse events and their incidence in placebo-controlled clinical trials. The table is divided by different body system adverse events schemes, such as the autonomic nervous system and psychiatric disorders. The percentage of patients reporting each event is also provided.*
FDA Label Image

Table 2 (Sertraline HCl Tablets New Ndc 3)

Table 2 (Sertraline HCl Tablets New Ndc 3)
This document seems to be a chart or a table with a list of medical disorders or adverse events possibly related to the medication PADD used for Social Anxiety Disorder. The first row contains the title, "PADD Social Anxiety Disorder," while the subsequent rows contain different types of disorders such as Autonomic Nervous System Disorders, Somnolence, Tremor, Dry Mouth, etc, and their respective occurrence rates in a placebo-controlled clinical trial. Some of the symptoms measured include sweating, dizziness, constipation, loss of appetite among others.*
FDA Label Image

Table 3 (Sertraline HCl Tablets New Ndc 4)

Table 3 (Sertraline HCl Tablets New Ndc 4)
The text describes a Table 3 that shows the incidence of treatment-emergent adverse events in placebo-controlled clinical trials for various mental health disorders such as major depressive disorder, OCD, panic disorder, PTSD, PMDD, and social anxiety disorder. The table also shows the percentage of patients reporting each event for various body systems such as autonomic nervous system disorders, central and peripheral nervous system disorders, disorders of skin and appendages, gastrointestinal disorders, general disorders, and psychiatric disorders. The adverse events include ejaculation failure, mouth dryness, increased sweating, somnolence, dizziness, headache, paresthesia, tremor, rash, anorexia, constipation, diarrhea/loose stools, dyspepsia, nausea, vomiting, fatigue, agitation, anxiety, insomnia, decreased libido, nervousness, and abnormal vision.*
FDA Label Image

Table 4 (Sertraline HCl Tablets New Ndc 5)

Table 4 (Sertraline HCl Tablets New Ndc 5)
This appears to be the table showing the most common adverse events associated with discontinuation in placebo-controlled clinical trials for various mental health conditions such as Major Depressive Disorder, Premenstrual Dysphoric Disorder, PTSD, Anxiety Disorder, etc. The table lists the percentages of patients who discontinued the trials due to adverse events. However, it is not clear what the values represent in the column headings as there are missing characters and symbols.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.